Compare RXO & CNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RXO | CNC |
|---|---|---|
| Founded | 2022 | 1984 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Medical Specialities |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.2B | 21.5B |
| IPO Year | 2022 | 2001 |
| Metric | RXO | CNC |
|---|---|---|
| Price | $13.13 | $34.46 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 15 | 17 |
| Target Price | $16.46 | ★ $41.94 |
| AVG Volume (30 Days) | 1.7M | ★ 4.9M |
| Earning Date | 05-06-2026 | 04-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 72.81 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $5,742,000,000.00 | ★ $194,777,000,000.00 |
| Revenue This Year | $0.78 | $8.29 |
| Revenue Next Year | $6.58 | $1.26 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 26.20 | 19.44 |
| 52 Week Low | $10.43 | $25.08 |
| 52 Week High | $19.65 | $66.03 |
| Indicator | RXO | CNC |
|---|---|---|
| Relative Strength Index (RSI) | 42.42 | 32.16 |
| Support Level | $12.33 | $33.27 |
| Resistance Level | $16.88 | $38.67 |
| Average True Range (ATR) | 0.95 | 1.46 |
| MACD | -0.10 | -0.59 |
| Stochastic Oscillator | 24.02 | 5.38 |
RXO Inc is a brokered transportation platform defined by cutting-edge technology and a nimble, asset-light business model, with the component being core truck brokerage business. Its operations also include three asset-light, brokered transportation services, all of which complement its truck brokerage business: managed transportation, last mile and freight forwarding. The company operates into one reportable segment. The operates within the transportation industry and in the same geography North America.
Centene is a managed care organization that focuses on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 22 million medical members as of December 2024, mostly in Medicaid (about 60% of membership), the individual exchanges (about 20%), and Medicare (about 5%). The company also has a military contract and provides Medicare Part D pharmaceutical plans.